An end to animal testing: How animal-friendly affinity-reagents are transforming research

#Act4
LabAnimals

An end to animal testing: How animal-friendly affinity-reagents are transforming research

1 December 2020
News
Afability founder, Dr. Alison Gray, a molecular biologist and in vitrotoxicologist is determined to not only replace the use of animals in scientific research, but to offer proven, scientifically superior alternatives that will positively impact society.

To help achieve this goal, Gray founded the non-commercial organization AFABILITY (AFA meaning animal-friendly affinity-reagents) in 2016. This unique organization brings together a wealth of expertise in scientific, animal welfare, and regulatory domains to achieve its mission of promoting the benefits of AFAs, in antibody generation and production. As AFAs do not require the use of animals, an increase in their usage would significantly reduce the suffering of animals in biomedical sciences.

 

AFABILITY challenges the enforcement of Directive 2010/63/EU and regulatory legislation on the use of animal-derived antibody (ADA) production techniques as a scientific procedure. Where alternatives exist, the organization creates awareness across all public sectors. AFABILITY improves the availability of AFA replacement methods via the distribution of educational and technical resources to individual scientists, organizations, and companies who want to implement, develop, acquire, or be informed about AFAs. AFABILITY is a non-commercial, scientific organization, providing scientists with affordable solutions and facilitating the uptake of AFA production methods. Funding allows AFABILITY to maintain its unique position without seeking commercial gain.